Ms. Debra Lynne, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 6750 Mccoy Rd, Rickreall, OR 97371 Phone: 541-231-7897 |
News Archive
New research from UBC shows that when humans speed up the usually slow process of evolution by introducing new species, it can result in a lasting impact on the ecosystem. The phenomenon is known as reverse speciation and researchers witnessed it in Enos Lake on Vancouver Island where two similar species of threespine stickleback fish disappeared within three years.
AstraZeneca today announced top-line results of OSKIRA-4, a Phase IIb monotherapy study of fostamatinib, the first kinase inhibitor with selectivity for SYK (spleen tyrosine kinase) in development as an oral treatment for rheumatoid arthritis (RA).
A newly developed test could make checking DNA from people arrested for crimes with DNA samples from crime scenes stored in forensic databases almost as easy as matching fingerprints. With the test, police could check on whether a person's DNA matches that found at past crime scenes while suspects are still being processed and before a decision on whether to release them on bail. A report on the fast forensic test appears in the ACS' Analytical Chemistry, a semi-monthly journal.
Three new oral blood-thinning drugs nearing approval by the Food and Drug Administration are more convenient than the standard drug Coumadin® because they do not require monthly visits to adjust doses.
A new study by radiation oncologists at Mayo Clinic comparing the world's literature on outcomes of proton beam therapy in the treatment of a variety of advanced head and neck cancers of the skull base compared to intensity modulated radiation therapy (IMRT) has found that proton beam therapy significantly improved disease free survival and tumor control when compared to IMRT.
› Verified 9 days ago